Nifty

:

11504.95

Sensex

:

38845.82

-11.15 (-0.10%)
-134.03 (-0.34%)

Login

Nifty
Sensex

:
:

11504.95
38845.82

-11.15 (-0.10%)
-134.03 (-0.34%)

Kopran Ltd.

Pharmaceuticals & Drugs

Rating :

71/99

BSE: 524280 | NSE: KOPRAN

Watchlist

NSE BSE

88.45

18-Sep-2020

Open
High
Low
Previous Close

87.00
88.45
86.15
84.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

620313
546.75
88.45
15.10

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

365.48
11.78
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

449.01
N/A
1.79

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.45
3.94
4.69

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.97
9.09
9.96

PAT CAGR (%)

10 Years
5 Years
3 Years

16.59
14.42
0.85

P:E (Median)

8 Years
5 Years
3 Years

8.84
9.99
8.04

P:BV (Average)

8 Years
5 Years
3 Years

1.68
1.82
1.29

EV:EBITDA (Average)

8 Years
5 Years
3 Years

6.78
7.14
6.03

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 57.23 37.74 51.64% 38.59 58.11 -33.59% 54.68 61.85 -11.59% 48.29 49.01 -1.47%
Expenses 48.79 35.45 37.63% 34.18 52.29 -34.63% 45.53 52.87 -13.88% 44.25 43.76 1.12%
EBITDA 8.45 2.29 269.00% 4.41 5.82 -24.23% 9.14 8.97 1.90% 4.04 5.24 -22.90%
EBIDTM 14.76% 6.06% 11.43% 10.02% 16.72% 14.51% 8.36% 10.70%
Other Income 2.40 1.93 24.35% 0.52 2.95 -82.37% 1.24 1.56 -20.51% 1.60 0.63 153.97%
Interest 1.46 1.34 8.96% 1.48 1.70 -12.94% 1.90 1.35 40.74% 1.25 1.46 -14.38%
Depreciation 0.96 0.80 20.00% 0.87 0.78 11.54% 0.86 0.77 11.69% 0.95 0.78 21.79%
PBT 8.43 2.08 305.29% 2.59 6.29 -58.82% 7.62 8.42 -9.50% 3.45 3.64 -5.22%
Tax 2.41 0.57 322.81% 0.79 2.38 -66.81% 2.14 1.43 49.65% 1.01 0.86 17.44%
PAT 6.02 1.51 298.68% 1.80 3.91 -53.96% 5.48 6.99 -21.60% 2.43 2.77 -12.27%
PATM 10.52% 4.00% 4.66% 6.72% 10.02% 11.31% 5.04% 5.66%
EPS 1.39 0.35 297.14% 0.42 0.90 -53.33% 1.27 1.61 -21.12% 0.56 0.64 -12.50%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 120.88 84.15 43.65% 87.38 99.71 -12.37% 100.19 105.49 -5.02% 87.78 92.15 -4.74%
Expenses 100.77 76.59 31.57% 75.92 87.93 -13.66% 88.02 89.61 -1.77% 77.13 82.08 -6.03%
EBITDA 20.11 7.56 166.01% 11.46 11.78 -2.72% 12.17 15.88 -23.36% 10.65 10.07 5.76%
EBIDTM 16.64% 8.98% 13.11% 11.82% 12.14% 15.05% 12.14% 10.93%
Other Income 3.52 2.48 41.94% 0.18 4.41 -95.92% 1.40 1.78 -21.35% 1.44 0.28 414.29%
Interest 1.86 2.09 -11.00% 2.23 2.44 -8.61% 2.62 2.15 21.86% 1.97 2.79 -29.39%
Depreciation 2.54 2.30 10.43% 2.40 2.22 8.11% 2.41 2.18 10.55% 2.48 2.19 13.24%
PBT 19.24 5.64 241.13% 6.46 11.53 -43.97% 8.53 13.33 -36.01% 7.65 5.37 42.46%
Tax 5.00 1.42 252.11% 1.65 3.85 -57.14% 2.22 2.47 -10.12% 1.98 1.08 83.33%
PAT 14.23 4.22 237.20% 4.81 7.68 -37.37% 6.31 10.86 -41.90% 5.67 4.29 32.17%
PATM 11.77% 5.02% 5.50% 7.70% 6.30% 10.30% 6.46% 4.66%
EPS 3.29 0.98 235.71% 1.11 1.77 -37.29% 1.46 2.51 -41.83% 1.31 0.99 32.32%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 198.79 179.29 196.65 153.70 181.54 187.31 325.58 301.96 250.22 198.91 192.38 Net Sales Growth -3.83% -8.83% 27.94% -15.34% -3.08% -42.47% 7.82% 20.68% 25.80% 3.39% Cost Of Goods Sold 113.79 85.66 102.32 76.79 95.43 102.51 194.20 171.39 141.83 116.72 114.37 Gross Profit 85.00 93.63 94.32 76.90 86.11 84.80 131.39 130.57 108.39 82.18 78.01 GP Margin 42.76% 52.22% 47.96% 50.03% 47.43% 45.27% 40.36% 43.24% 43.32% 41.32% 40.55% Total Expenditure 172.75 156.11 173.95 146.44 164.19 162.37 293.97 259.34 215.92 177.22 173.78 Power & Fuel Cost - 6.21 6.30 5.04 4.47 4.43 12.93 11.71 11.13 8.56 9.03 % Of Sales - 3.46% 3.20% 3.28% 2.46% 2.37% 3.97% 3.88% 4.45% 4.30% 4.69% Employee Cost - 20.02 20.38 18.34 19.12 16.05 28.83 22.96 20.48 17.52 17.34 % Of Sales - 11.17% 10.36% 11.93% 10.53% 8.57% 8.85% 7.60% 8.18% 8.81% 9.01% Manufacturing Exp. - 22.79 23.93 23.43 21.43 17.76 30.11 27.00 17.79 15.85 16.17 % Of Sales - 12.71% 12.17% 15.24% 11.80% 9.48% 9.25% 8.94% 7.11% 7.97% 8.41% General & Admin Exp. - 13.46 12.53 13.71 12.18 11.77 15.14 14.44 11.27 9.83 9.07 % Of Sales - 7.51% 6.37% 8.92% 6.71% 6.28% 4.65% 4.78% 4.50% 4.94% 4.71% Selling & Distn. Exp. - 6.78 7.01 6.65 6.91 7.17 8.16 8.85 6.56 5.85 4.64 % Of Sales - 3.78% 3.56% 4.33% 3.81% 3.83% 2.51% 2.93% 2.62% 2.94% 2.41% Miscellaneous Exp. - 1.20 1.48 2.48 4.65 2.67 4.61 3.00 6.87 2.88 4.64 % Of Sales - 0.67% 0.75% 1.61% 2.56% 1.43% 1.42% 0.99% 2.75% 1.45% 1.65% EBITDA 26.04 23.18 22.70 7.26 17.35 24.94 31.61 42.62 34.30 21.69 18.60 EBITDA Margin 13.10% 12.93% 11.54% 4.72% 9.56% 13.31% 9.71% 14.11% 13.71% 10.90% 9.67% Other Income 5.76 1.99 3.22 9.56 9.12 0.83 6.49 1.34 1.72 5.56 6.38 Interest 6.09 5.96 5.46 6.63 9.79 9.99 12.97 14.46 11.88 9.66 8.61 Depreciation 3.64 3.47 3.11 3.22 3.34 3.14 9.58 12.46 12.08 11.42 11.23 PBT 22.09 15.73 17.36 6.96 13.35 12.63 15.55 17.04 12.06 6.17 5.13 Tax 6.35 4.51 4.39 2.25 4.85 0.00 0.00 0.00 0.00 0.00 -0.27 Tax Rate 28.75% 28.67% 25.29% 32.33% 36.33% 0.00% 0.00% 0.00% 0.00% 0.00% -5.26% PAT 15.73 11.22 12.97 4.71 8.50 11.44 15.48 17.04 12.06 6.17 5.40 PAT before Minority Interest 15.73 11.22 12.97 4.71 8.50 11.44 15.48 17.04 12.06 6.17 5.40 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.91% 6.26% 6.60% 3.06% 4.68% 6.11% 4.75% 5.64% 4.82% 3.10% 2.81% PAT Growth 3.62% -13.49% 175.37% -44.59% -25.70% -26.10% -9.15% 41.29% 95.46% 14.26% EPS 3.63 2.59 3.00 1.09 1.96 2.64 3.58 3.94 2.79 1.42 1.25

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 396.23 359.50 357.90 313.32 309.72 296.32 325.73 302.85 250.22 198.90 192.38 Net Sales Growth 3.86% 0.45% 14.23% 1.16% 4.52% -9.03% 7.55% 21.03% 25.80% 3.39% Cost Of Goods Sold 231.72 192.78 190.88 171.87 164.89 166.92 194.27 172.22 141.88 116.77 114.40 Gross Profit 164.51 166.72 167.02 141.44 144.82 129.39 131.46 130.63 108.34 82.13 77.99 GP Margin 41.52% 46.38% 46.67% 45.14% 46.76% 43.67% 40.36% 43.13% 43.30% 41.29% 40.54% Total Expenditure 341.84 312.80 312.47 284.27 273.60 266.09 294.29 260.25 216.57 177.75 174.33 Power & Fuel Cost - 18.08 17.10 14.90 13.71 14.10 12.93 11.71 11.13 8.56 9.03 % Of Sales - 5.03% 4.78% 4.76% 4.43% 4.76% 3.97% 3.87% 4.45% 4.30% 4.69% Employee Cost - 36.85 37.11 32.24 31.37 28.02 28.83 23.01 21.03 17.98 17.85 % Of Sales - 10.25% 10.37% 10.29% 10.13% 9.46% 8.85% 7.60% 8.40% 9.04% 9.28% Manufacturing Exp. - 30.07 32.41 31.35 31.84 27.80 25.56 22.44 17.79 15.85 16.17 % Of Sales - 8.36% 9.06% 10.01% 10.28% 9.38% 7.85% 7.41% 7.11% 7.97% 8.41% General & Admin Exp. - 20.99 18.92 19.20 16.93 15.68 15.38 14.46 11.32 9.86 9.08 % Of Sales - 5.84% 5.29% 6.13% 5.47% 5.29% 4.72% 4.77% 4.52% 4.96% 4.72% Selling & Distn. Exp. - 9.36 9.18 9.56 8.46 9.35 8.16 8.85 6.56 5.85 4.64 % Of Sales - 2.60% 2.56% 3.05% 2.73% 3.16% 2.51% 2.92% 2.62% 2.94% 2.41% Miscellaneous Exp. - 4.68 6.86 5.15 6.39 4.22 9.17 7.57 6.87 2.88 4.64 % Of Sales - 1.30% 1.92% 1.64% 2.06% 1.42% 2.82% 2.50% 2.75% 1.45% 1.65% EBITDA 54.39 46.70 45.43 29.05 36.12 30.23 31.44 42.60 33.65 21.15 18.05 EBITDA Margin 13.73% 12.99% 12.69% 9.27% 11.66% 10.20% 9.65% 14.07% 13.45% 10.63% 9.38% Other Income 6.54 0.63 3.96 10.94 10.66 2.37 6.54 1.96 1.81 5.66 6.45 Interest 8.68 8.91 8.99 8.60 13.70 12.56 12.97 14.46 11.88 9.66 8.61 Depreciation 9.83 9.58 8.74 8.51 8.33 8.12 9.64 12.92 12.46 11.80 11.62 PBT 41.88 28.84 31.66 22.89 24.76 11.91 15.36 17.18 11.12 5.34 4.26 Tax 10.85 7.26 7.64 2.40 4.85 0.00 0.00 0.00 0.00 0.00 -0.27 Tax Rate 25.91% 25.66% 24.13% 10.48% 19.59% 0.00% 0.00% 0.00% 0.00% 0.00% -6.34% PAT 31.02 21.02 24.02 20.49 19.91 10.72 -39.12 17.18 11.12 5.34 4.53 PAT before Minority Interest 31.02 21.02 24.02 20.49 19.91 10.72 -39.12 17.18 11.12 5.34 4.53 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.83% 5.85% 6.71% 6.54% 6.43% 3.62% -12.01% 5.67% 4.44% 2.68% 2.35% PAT Growth 14.68% -12.49% 17.23% 2.91% 85.73% - - 54.50% 108.24% 17.88% EPS 7.16 4.85 5.55 4.73 4.60 2.48 -9.03 3.97 2.57 1.23 1.05

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 229.67 218.44 205.75 200.94 196.65 185.68 145.15 128.11 116.05 109.88 Share Capital 43.25 43.25 43.25 43.25 51.83 49.68 47.63 47.63 47.63 47.63 Total Reserves 186.42 175.19 162.50 157.69 144.82 121.81 97.52 80.48 68.42 62.25 Non-Current Liabilities 12.31 22.36 20.95 25.72 24.53 10.26 66.77 73.05 67.72 76.06 Secured Loans 0.15 0.25 0.34 0.25 0.33 0.63 0.68 2.94 5.49 7.42 Unsecured Loans 9.52 21.46 21.55 27.80 21.65 6.90 62.54 66.54 59.10 65.83 Long Term Provisions 3.88 3.60 2.81 2.58 2.55 2.73 3.55 3.57 3.13 2.81 Current Liabilities 83.87 74.81 69.91 79.21 57.57 78.68 117.07 91.88 95.64 79.91 Trade Payables 31.62 32.44 28.77 35.91 35.64 36.34 35.49 46.83 41.71 30.64 Other Current Liabilities 25.00 22.53 16.16 18.44 14.66 23.05 29.18 20.56 22.69 18.61 Short Term Borrowings 26.58 18.83 23.56 21.51 6.89 18.41 52.27 24.37 31.13 30.48 Short Term Provisions 0.67 1.01 1.41 3.36 0.38 0.88 0.14 0.12 0.11 0.18 Total Liabilities 325.85 315.61 296.61 305.87 278.75 274.62 328.99 293.04 279.41 265.85 Net Block 42.95 41.88 38.15 39.34 34.98 33.46 102.66 106.18 111.60 112.11 Gross Block 56.00 51.46 44.71 42.68 82.58 78.04 272.91 264.07 257.63 246.72 Accumulated Depreciation 13.05 9.58 6.56 3.34 47.60 44.58 170.24 157.90 146.02 134.61 Non Current Assets 211.62 208.18 204.70 201.98 196.00 81.47 168.68 169.94 172.79 174.71 Capital Work in Progress 7.07 6.75 7.84 4.44 0.19 0.19 0.84 0.93 0.00 0.04 Non Current Investment 158.14 157.52 156.92 156.60 156.07 46.07 6.87 6.87 6.87 6.87 Long Term Loans & Adv. 3.38 1.93 1.72 1.59 4.75 1.72 58.21 55.88 54.29 53.00 Other Non Current Assets 0.08 0.11 0.07 0.01 0.01 0.03 0.10 0.09 0.02 2.70 Current Assets 114.23 107.42 91.91 103.89 82.75 193.15 160.31 123.10 106.62 91.14 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 41.17 25.19 29.75 25.09 28.13 14.06 53.02 36.74 35.15 32.11 Sundry Debtors 42.48 44.59 20.13 38.33 19.63 29.06 54.64 49.61 37.52 33.36 Cash & Bank 1.15 1.05 1.53 1.72 4.35 3.62 4.54 3.63 9.52 0.75 Other Current Assets 29.44 4.69 3.37 1.31 30.64 146.41 48.11 33.12 24.44 24.92 Short Term Loans & Adv. 28.06 31.90 37.12 37.43 30.00 145.18 47.20 31.74 23.17 24.29 Net Current Assets 30.36 32.62 21.99 24.68 25.18 114.47 43.24 31.21 10.98 11.22 Total Assets 325.85 315.60 296.61 305.87 278.75 274.62 328.99 293.04 279.41 265.85

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 189.68 168.48 144.71 124.67 108.72 98.52 114.56 97.22 86.02 80.46 Share Capital 43.25 43.25 43.25 43.25 51.83 49.68 47.63 47.63 47.63 47.63 Total Reserves 146.43 125.23 101.46 81.42 56.89 34.65 66.93 49.59 38.39 32.84 Non-Current Liabilities 40.48 46.17 31.45 32.17 33.00 18.31 67.02 73.34 68.00 76.19 Secured Loans 0.15 0.28 0.44 0.33 0.33 0.63 0.68 2.94 5.49 7.42 Unsecured Loans 31.68 40.84 29.48 32.17 28.36 13.38 62.54 66.54 59.10 65.83 Long Term Provisions 7.20 6.42 5.14 4.59 4.31 4.31 3.55 3.60 3.16 2.84 Current Liabilities 140.05 134.71 135.53 136.49 122.08 158.21 117.45 92.75 96.43 80.65 Trade Payables 54.74 51.16 60.67 47.13 57.04 69.22 35.71 46.98 41.82 30.74 Other Current Liabilities 38.17 35.24 21.30 29.91 26.64 36.70 29.33 20.74 22.85 18.72 Short Term Borrowings 46.23 45.44 52.11 56.09 38.00 51.38 52.27 24.90 31.66 31.01 Short Term Provisions 0.91 2.87 1.45 3.36 0.41 0.90 0.14 0.12 0.12 0.18 Total Liabilities 370.21 349.36 311.69 293.33 263.80 275.04 299.03 263.31 250.45 237.30 Net Block 111.15 112.62 104.44 104.47 100.88 101.56 104.89 108.51 114.32 115.21 Gross Block 146.31 138.14 121.27 112.80 314.06 306.73 295.95 286.76 280.31 269.40 Accumulated Depreciation 35.16 25.52 16.84 8.33 213.18 205.18 191.06 178.25 165.99 154.19 Non Current Assets 147.61 141.79 118.20 113.62 109.78 105.06 139.33 140.69 143.91 147.76 Capital Work in Progress 30.24 24.29 9.93 6.29 3.13 1.23 19.76 19.85 18.92 18.96 Non Current Investment 0.02 0.02 0.05 0.05 0.11 0.11 0.81 0.81 0.81 0.96 Long Term Loans & Adv. 4.90 3.54 2.47 2.30 5.61 2.09 13.76 11.43 9.83 9.93 Other Non Current Assets 1.29 1.32 1.31 0.50 0.03 0.06 0.10 0.09 0.02 2.70 Current Assets 222.60 207.57 193.50 179.72 154.01 169.98 159.70 122.61 106.54 89.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 88.50 73.45 71.01 60.56 58.84 45.30 53.02 36.74 35.15 32.11 Sundry Debtors 92.81 86.64 64.77 73.11 56.89 81.17 56.03 51.18 39.01 34.49 Cash & Bank 4.75 3.96 6.18 6.88 4.71 3.73 4.71 3.79 9.66 0.86 Other Current Assets 36.55 5.54 3.97 1.83 33.58 39.78 45.93 30.91 22.73 22.09 Short Term Loans & Adv. 34.26 37.98 47.57 37.33 32.65 38.23 45.02 29.53 21.46 21.46 Net Current Assets 82.55 72.85 57.96 43.23 31.93 11.78 42.25 29.86 10.11 8.90 Total Assets 370.21 349.36 311.70 293.34 263.79 275.04 299.03 263.30 250.45 237.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 9.97 11.84 12.50 4.20 18.66 52.59 1.88 13.64 35.11 19.61 PBT 15.73 17.36 6.96 13.35 11.44 15.48 17.04 12.06 6.17 5.13 Adjustment 11.64 3.32 6.04 15.81 13.21 22.39 26.04 22.13 18.35 16.94 Changes in Working Capital -13.53 -4.90 2.52 -24.06 -5.95 14.75 -41.15 -20.48 10.55 -2.37 Cash after chg. in Working capital 13.84 15.77 15.52 5.10 18.70 52.62 1.92 13.70 35.06 19.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.87 -3.94 -3.02 -0.91 -0.04 -0.03 -0.04 -0.06 0.05 -0.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.63 -4.47 -1.93 -8.88 -3.65 -9.51 -8.97 -8.08 -9.95 0.69 Net Fixed Assets -4.86 -5.66 -5.43 35.65 -4.54 195.52 -8.75 -7.37 -10.87 -4.91 Net Investments -0.62 -0.60 -0.32 -0.53 -110.00 -39.20 0.00 0.00 0.00 3.52 Others 6.11 1.79 3.82 -44.00 110.89 -165.83 -0.22 -0.71 0.92 2.08 Cash from Financing Activity -10.60 -7.43 -10.71 4.64 -14.99 -43.25 7.22 -12.13 -18.84 -20.20 Net Cash Inflow / Outflow 0.00 -0.06 -0.14 -0.04 0.02 -0.17 0.12 -6.57 6.32 0.10 Opening Cash & Equivalents 0.21 0.27 0.42 0.47 0.45 0.62 0.49 7.07 0.75 0.64 Closing Cash & Equivalent 0.21 0.21 0.27 0.42 0.47 0.45 0.62 0.49 7.07 0.75

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 31.00 25.41 25.77 15.87 28.63 46.30 2.79 14.88 35.01 17.79 PBT 28.84 31.66 22.89 24.76 10.72 -39.12 17.18 11.12 5.34 4.26 Adjustment 21.84 13.22 13.52 25.15 19.63 76.87 25.97 22.52 18.74 21.51 Changes in Working Capital -11.98 -15.59 -7.56 -33.13 -1.71 8.58 -40.32 -18.68 10.88 -7.89 Cash after chg. in Working capital 38.70 29.30 28.84 16.78 28.64 46.32 2.82 14.95 34.96 17.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -7.15 -3.88 -3.07 -0.91 -0.01 -0.02 -0.04 -0.07 0.04 -0.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -0.55 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -12.52 -24.86 -10.96 -17.96 -9.07 -9.62 -9.33 -9.31 -9.81 1.01 Net Fixed Assets -4.86 -5.66 -5.43 35.65 -4.54 195.52 -8.75 -7.37 -10.87 -4.91 Net Investments -0.62 -0.60 -0.32 -0.53 -110.00 -39.20 0.00 0.00 0.00 3.52 Others -7.04 -18.60 -5.21 -53.08 105.47 -165.94 -0.58 -1.94 1.06 2.40 Cash from Financing Activity -18.06 -0.58 -15.02 1.97 -19.34 -36.90 6.69 -12.14 -18.84 -18.70 Net Cash Inflow / Outflow 0.42 -0.03 -0.21 -0.12 0.22 -0.22 0.14 -6.56 6.35 0.10 Opening Cash & Equivalents 0.41 0.44 0.66 0.78 0.56 0.79 0.65 7.21 0.86 0.76 Closing Cash & Equivalent 0.83 0.41 0.44 0.66 0.78 0.56 0.79 0.65 7.21 0.86

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 53.10 50.51 47.57 46.46 43.48 39.64 34.97 30.61 27.52 25.94 ROA 3.50% 4.24% 1.56% 2.91% 4.13% 5.13% 5.48% 4.21% 2.26% 2.04% ROE 5.01% 6.12% 2.31% 4.37% 6.52% 10.34% 13.31% 10.63% 5.91% 5.53% ROCE 7.98% 8.67% 5.28% 9.50% 9.45% 11.44% 12.49% 10.66% 7.24% 6.37% Fixed Asset Turnover 3.34 4.09 3.52 2.90 2.33 1.91 1.16 0.99 0.81 0.82 Receivable days 88.59 60.06 69.42 58.23 47.41 45.65 61.12 61.79 63.11 57.22 Inventory Days 67.52 50.99 65.12 53.47 41.08 36.58 52.63 50.98 59.89 53.30 Payable days 73.19 68.99 86.47 86.61 86.52 46.47 59.00 76.08 76.10 76.76 Cash Conversion Cycle 82.91 42.06 48.07 25.09 1.98 35.75 54.76 36.69 46.90 33.76 Total Debt/Equity 0.20 0.23 0.25 0.28 0.17 0.22 0.89 0.80 0.88 0.99 Interest Cover 3.64 4.18 2.05 2.36 2.14 2.19 2.18 2.02 1.64 1.60

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 43.86 38.95 33.46 28.83 23.15 18.43 27.14 22.70 19.83 18.41 ROA 5.84% 7.27% 6.77% 7.15% 3.98% -13.63% 6.11% 4.33% 2.19% 1.92% ROE 11.74% 15.34% 15.21% 17.71% 12.19% -43.06% 17.65% 13.39% 7.15% 6.60% ROCE 13.69% 16.30% 13.88% 19.24% 13.09% -12.48% 14.27% 11.81% 7.92% 6.88% Fixed Asset Turnover 2.53 2.76 2.69 1.49 0.98 1.11 1.07 0.91 0.75 0.75 Receivable days 91.10 77.21 79.96 74.44 82.54 74.79 62.68 63.96 65.44 58.23 Inventory Days 82.21 73.66 76.30 68.37 62.26 53.60 52.48 50.98 59.89 53.30 Payable days 60.78 68.76 72.54 73.61 89.54 68.97 60.02 75.95 75.92 76.75 Cash Conversion Cycle 112.53 82.11 83.72 69.21 55.25 59.43 55.14 38.99 49.41 34.78 Total Debt/Equity 0.47 0.58 0.61 0.76 0.65 0.92 1.12 1.06 1.20 1.36 Interest Cover 4.17 4.52 3.66 2.81 1.85 -2.02 2.19 1.94 1.55 1.50

Annual Reports:

News Update:

Kopran’s arm receives approval from USFDA for supply of API Atenolol
18th Jun 2020, 14:39 PM

The company had filed the DMF of Atenolol, which has now been approved by the USFDA
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback